EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal Study of TCF4 CTG Trinucleotide Repeat Length and Disease Severity in Fuchs’ Endothelial Corneal Dystrophy

Jasmin X J Teo iD, Dawn J H Neo iD, Jessica Q H Choo iD, Xin Gong, Zheng Li iD, Hla Myint Htoon, Min Jie Chua, Yu Qiang Soh, V Vinod Mootha iD, Chiea Chuen Khor, Jodhbir S Mehta

Medical Sciences · 2026

DOI: 10.3390/medsci14010031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2026. Verfasst von Jasmin X J Teo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Singapore Eye Research Institute, Singapore 169856, Singapore. Hauptthemen laut MEDLINE: Fuchs' Endothelial Dystrophy, Transcription Factor 4, Trinucleotide Repeat Expansion, Trinucleotide Repeats. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Biomedical Sciences (HBMS), Singapore - Industry Alignment Fund, The Molecular Therapeutics Programme, SingHealth Fund - The Molecular Therapeutics Programme, Health and Biomedical Sciences (HBMS), Singapore—Industry Alignment Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This was a longitudinal study of TCF4 CTG18.1 trinucleotide repeat lengths in 17 patients (27 eyes) diagnosed with Fuchs’ endothelial corneal dystrophy (FECD), and it aimed to correlate the repeat expansion status with disease severity and progression.

Design

This was a prospective cohort study looking at FECD clinical progression and TCF4 CTG18.1 repeat length expansion status over time.

Methods

A total of 27 eyes from 17 patients diagnosed with FECD were recruited. Only eyes with FECD disease severity of at least Grade 4 on the modified Krachmer clinical grading scale were included; eyes that had previously undergone any form of ocular surgery prior to the first genotyping or during the duration of follow-up were excluded. CTG trinucleotide repeat genotyping was performed on peripheral blood leukocytes at two time points over an average follow-up of 10 years. Over the follow-up period, the FECD progression of each subject was examined using pachymetry, Scheimpflug imaging (Pentacam), and endothelial cell density (ECD) readings, during the baseline visit, yearly thereafter, at the time of repeat CTG18.1 genotyping, and at their latest visit. Main Outcome Measures: The clinical progression of FECD patients was assessed using central corneal thickness (CCT), ECD, and any keratoplasty performed. CTG repeat length was assessed twice over the entire follow-up period.

Results

The non-expanded alleles were shown to be stable over the period of follow-up and did not develop any expanded repeats. Repeat expansion did not influence the risk of attaining Threshold Disease, although more patients in the L ≥ 40 group (CTG18.1 repeat sequence of more than or equal to 40 repeats) underwent keratoplasty.

Conclusions

Through this study, we found that the CTG18.1 allele lengths of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fuchs' Endothelial DystrophyTranscription Factor 4Trinucleotide Repeat ExpansionTrinucleotide RepeatsHumansFemaleMaleLongitudinal StudiesAgedMiddle AgedProspective StudiesGenotypeDisease ProgressionSeverity of Illness Index

Stichwörter der Autor:innen

CTG trinucleotide repeat expansionFuchs’ endothelial corneal dystrophyTCF4 gene

Substanzen

Transcription Factor 4TCF4 protein, human

Autor:innen und Institutionen

  • Singapore Eye Research Institute, Singapore 169856, Singapore.
  • Singapore National Eye Centre, Singapore 168751, Singapore.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
  • Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore 138672, Singapore.
  • Ophthalmology and Visual Sciences Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore.

ORCID-Profile: Jasmin X J Teo, Dawn J H Neo, Jessica Q H Choo, Zheng Li, V Vinod Mootha

Förderung

  • Health and Biomedical Sciences (HBMS), Singapore - Industry Alignment Fund, The Molecular Therapeutics Programme
  • SingHealth Fund - The Molecular Therapeutics Programme
  • Health and Biomedical Sciences (HBMS), Singapore—Industry Alignment Fund
  • SingHealth Fund

Zitieren

APA

Teo, J. X. J., Neo, D. J. H., Choo, J. Q. H., Gong, X., Li, Z., Htoon, H. M., Chua, M. J., Soh, Y. Q., Mootha, V. V., Khor, C. C., & Mehta, J. S. (2026). Longitudinal Study of TCF4 CTG Trinucleotide Repeat Length and Disease Severity in Fuchs’ Endothelial Corneal Dystrophy. Medical Sciences. https://doi.org/10.3390/medsci14010031

Vancouver

Teo JXJ, Neo DJH, Choo JQH, Gong X, Li Z, Htoon HM, et al. Longitudinal Study of TCF4 CTG Trinucleotide Repeat Length and Disease Severity in Fuchs’ Endothelial Corneal Dystrophy. Medical Sciences. 2026. doi:10.3390/medsci14010031

BibTeX
@article{Teo2026,
  author = {Teo, Jasmin X J and Neo, Dawn J H and Choo, Jessica Q H and Gong, Xin and Li, Zheng and Htoon, Hla Myint and Chua, Min Jie and Soh, Yu Qiang and Mootha, V Vinod and Khor, Chiea Chuen and Mehta, Jodhbir S},
  title = {Longitudinal Study of TCF4 CTG Trinucleotide Repeat Length and Disease Severity in Fuchs’ Endothelial Corneal Dystrophy},
  journal = {Medical Sciences},
  year = {2026},
  doi = {10.3390/medsci14010031}
}
Kostenlos starten →